A study reveals that gut bacteria impact tamoxifen’s effectiveness in breast cancer treatment. Certain bacterial enzymes enhance the drug's recycling into the bloodstream, improving its efficacy.
Tamoxifen is a common and important treatment to prevent breast cancer from recurring. A new study shows that variation in a patient's gut microbiome can impact how effective the treatment is.
A new study has shown that variation in the microbiota of the human gut impacts the pharmacokinetics of tamoxifen and thus the effectiveness of the drug.